In this dissertation, I incorporate the external competitive environment into the analysis of governance choice of technology projects and performance implications of such governance choice. From the perspective of R&D firms, I develop a theoretical framework that categorizes competitors in a technology domain into two groups R&D firms and vertically integrated firms. Furthermore, I identify the underlying mechanisms that drive the relationship between the presence of heterogeneous competitors and a R&D firm's choice of three alternative governance modes: internal organization, equity alliance and non-equity alliance. I test the framework on a unique data set that contains history of clinical trials in 24 therapeutic areas in the US biotechnology industry between 1996 to 2008.
University of Miinesoota Ph.D. dissertation. February 2011. Major: Business Administration. Advisor: J. Myles Shaver. 1 computer file (PDF); x, 152 p. appendix p. 128-152.
Effects of competition on governance choice and project performance: evidence from clinical trials in the biotechnology industry..
Retrieved from the University of Minnesota Digital Conservancy,
Content distributed via the University of Minnesota's Digital Conservancy may be subject to additional license and use restrictions applied by the depositor.